Use of hypoxia inducible factor 2alpha for curing neonatal respiratory distress syndrome and as a target for the treatment of pulmonary hypertension

Details for Australian Patent Application No. 2002257794 (hide)

International Classifications

Event Publications

17 April 2003 Application Open to Public Inspection

Published as AU-B-2002257794

25 January 2007 Application Accepted

Published as AU-B-2002257794

15 February 2007 Corrigenda

Applications Accepted - Name Index Under the names Vlaams Interuniversitair Instituut voor Biotechnologie VZW and D. Collen Research Foundation Corrigenda VZW, Application No. 2002257794, under INID (71) correct the co-applicant name to read D. Collen Research Foundation

7 June 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.